# Clinical Study in Healthy Volunteers to Investigate the Neurocognitive Effects of a New Antiepileptic Drug: Brivaracetam

> **NCT00736931** · PHASE1 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 20 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Brivaracetam
- **DRUG:** levetiracetam
- **DRUG:** lorazepam
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00736931
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2012-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00736931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00736931, "Clinical Study in Healthy Volunteers to Investigate the Neurocognitive Effects of a New Antiepileptic Drug: Brivaracetam". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00736931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*